| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/25/2007 | EP1809287A2 Multiple layer coating composition |
| 07/25/2007 | EP1809286A2 Method for treatment of movement disorders |
| 07/25/2007 | EP1809285A1 Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
| 07/25/2007 | EP1809284A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/25/2007 | EP1809283A2 Morphine and morphine precursors |
| 07/25/2007 | EP1809282A2 Thiadiazole compounds and methods of use |
| 07/25/2007 | EP1809281A2 Use of epothilones in the treatment of bone metastases and bone tumors or cancers |
| 07/25/2007 | EP1809280A2 Mitotic kinesin inhibitors and methods of use thereof |
| 07/25/2007 | EP1809279A1 Nanoparticulate compositions of tubulin inhibitor |
| 07/25/2007 | EP1809278A2 Combinations of pkc activators and pkc inhibitors for for alzheimer's disease treatment and cognitive enhancement |
| 07/25/2007 | EP1809277A2 Phosphonate derivatives of mycophenolic acid |
| 07/25/2007 | EP1809276A2 Treatment method |
| 07/25/2007 | EP1809275A1 Chemical compounds |
| 07/25/2007 | EP1809274A2 Pharmaceutical composition for rectal or vaginal application comprising a platinum complex |
| 07/25/2007 | EP1809273A2 Use of 2-phenyl-1,2-ethanediol-(di)carbamates for treating epileptogenesis and epilepsy |
| 07/25/2007 | EP1809272A2 Methods and compositions for treatment of free radical injury |
| 07/25/2007 | EP1809271A2 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 07/25/2007 | EP1809270A1 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 07/25/2007 | EP1809269A1 Sugars and/or sugar alcohols for inhibiting and/or treating vaginal infection |
| 07/25/2007 | EP1809268A1 Use of caryophyllenes in the manufacture of medicaments and treatment of bodily conditions of inflammation and inflammatory pain |
| 07/25/2007 | EP1809267A1 Pharmaceutical compositions based on nk2 antagonists for pediatric use |
| 07/25/2007 | EP1809266A2 Anticancer compounds and methods |
| 07/25/2007 | EP1809265A2 Methods for the treatment of synucleinopathies |
| 07/25/2007 | EP1809263A1 New modif ied release peelet formulat ions for proton pump inhibitors |
| 07/25/2007 | EP1809262A1 New modified release tablet formulations for proton pump inhibitors |
| 07/25/2007 | EP1809255A1 High-dosage extended-release formulation of gepirone |
| 07/25/2007 | EP1809254A2 Lyophilized liposome formulations and method |
| 07/25/2007 | EP1809253A1 Stabilized freeze-dried formulation for cephalosporin derivatives |
| 07/25/2007 | EP1809251A2 Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane |
| 07/25/2007 | EP1809250A1 Dye-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent |
| 07/25/2007 | EP1809249A2 Multiparticulates of preferably an opioid, and method of manufacturing using extrusion |
| 07/25/2007 | EP1809247A1 Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
| 07/25/2007 | EP1809243A2 Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant |
| 07/25/2007 | EP1809241A2 Dye-free pharmaceutical suspensions and related methods |
| 07/25/2007 | EP1809239A1 Novel composition for easing human child birth |
| 07/25/2007 | EP1809236A1 Inhalation powder formulations containing enantiomerically pure beta-agonists |
| 07/25/2007 | EP1809125A1 Nutrition containing fat blend |
| 07/25/2007 | EP1809107A2 Compositions and methods of dispensing palliative or therapeutic agents |
| 07/25/2007 | EP1809104A2 Methods for regulating neurotransmitter systems by inducing counteradaptations |
| 07/25/2007 | EP1725215B1 Method and apparatus for producing carrier complexes |
| 07/25/2007 | EP1718313A4 Synergistic anti-inflammatory pharmaceutical compositions and methods of use |
| 07/25/2007 | EP1697306B1 Selective peroxisome proliferator activated receptor modulators |
| 07/25/2007 | EP1685096B1 Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same |
| 07/25/2007 | EP1658272B1 Novel gamma-secretase inhibitors |
| 07/25/2007 | EP1611161B1 Method to produce a solid form of heparin |
| 07/25/2007 | EP1581207A4 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 07/25/2007 | EP1572628B1 Isophtalic acid derivatives |
| 07/25/2007 | EP1556389B1 Cephem compounds |
| 07/25/2007 | EP1553933B1 Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent |
| 07/25/2007 | EP1537133B1 Partial and full agonists of a1 adenosine receptors |
| 07/25/2007 | EP1534346A4 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 07/25/2007 | EP1496076B1 Hydrophilic polymer derivate with y type branch and preparation method of it medical composite comprising above compound |
| 07/25/2007 | EP1448562B1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 07/25/2007 | EP1444236B1 Separation of regioisomers of metal phthalocyanines |
| 07/25/2007 | EP1432783B1 Decontamination of surfaces contaminated with prion-infected material with gaseous oxidizing agents |
| 07/25/2007 | EP1427383B1 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/25/2007 | EP1419772B1 Preventive agent/remedial agent for constipation predominant ibs |
| 07/25/2007 | EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | EP1397130B1 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 07/25/2007 | EP1383502A4 Compounds and methods for the treatment of urogenital disorders |
| 07/25/2007 | EP1370265B1 Hiv inhibiting pyrazinone derivatives |
| 07/25/2007 | EP1370257B1 COMPOSITION FOR THE PREVENTION OF OSTEOPOROSIS consisting of A COMBINATION OF ISOFLAVONES AND POLYUNSATURATED FATTY ACIDS |
| 07/25/2007 | EP1365765B1 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
| 07/25/2007 | EP1357892B1 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
| 07/25/2007 | EP1355873B1 Pleuromutilin derivatives with antimicrobial activity |
| 07/25/2007 | EP1351940B1 Substituted quinolines for the treatment of protozoan and retrovirus co-infections |
| 07/25/2007 | EP1349580B1 Process to improve stability of a pharmaceutical composition |
| 07/25/2007 | EP1335711B1 Transdermal device |
| 07/25/2007 | EP1330273B1 Coated implantable medical device |
| 07/25/2007 | EP1325000B1 A thiazolidinedione derivative and its use as antidiabetic |
| 07/25/2007 | EP1322289B1 Spray drying process of compositions containing fenofibrate |
| 07/25/2007 | EP1299100B1 Method of treating hot flashes, using tachykinin receptor antagonist |
| 07/25/2007 | EP1286664B1 Combination of low dose estrogen and immunotherapeutic agent for treating immune diseases |
| 07/25/2007 | EP1282610B1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/25/2007 | EP1263763B1 Tubulin binding ligands |
| 07/25/2007 | EP1189622B1 Anionic polymers as toxin binders and antibacterial agents |
| 07/25/2007 | EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands |
| 07/25/2007 | EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/25/2007 | EP1071419B1 Cannabinoids as antioxidants and neuroprotectants |
| 07/25/2007 | EP1056462B1 Use of rhamnolipids as cosmetics |
| 07/25/2007 | EP1042352B1 Androgenic steroid compounds and a method of making and using the same |
| 07/25/2007 | EP1005465B1 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 07/25/2007 | EP0820281B1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses |
| 07/25/2007 | EP0698092B1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 07/25/2007 | CN1328387C Amino alcohol derivatives |
| 07/25/2007 | CN1328291C 新的脱乙酰壳多糖 The new chitosan |
| 07/25/2007 | CN1328286C Aglyco products and method of use |
| 07/25/2007 | CN1328280C Tetrandrine and tetrandrine compound, synthesis and uses thereof |
| 07/25/2007 | CN1328279C Viral inhibitors |
| 07/25/2007 | CN1328263C Tetrahydroisoquinoline derivative, its preparation method and pharmaceutical composition |
| 07/25/2007 | CN1328260C Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1328259C Alpha crystalline form of perindopril tert-butyllamine salt |
| 07/25/2007 | CN1328258C Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 07/25/2007 | CN1327927C Cell separation compositions and methods |
| 07/25/2007 | CN1327870C Exterior-applied medicine for treating dermatopathy |
| 07/25/2007 | CN1327862C Compound liquorice lozenge and preparation process thereof |
| 07/25/2007 | CN1327860C Prepared Chinese medicine for treating yang disease of boil caused by accumulated noxious heat |
| 07/25/2007 | CN1327852C A health food possessing immunity regulating function and method for preparing the same |